OSLO - October 24, 2022: SoftOx Solutions AS ("SoftOx" or the "Company"), a
medtech and clinical-stage pharmaceutical company based in Oslo, Norway, will
release its third quarter 2022 results on Wednesday, October 26, 2022 at 07:00
(CET). The report and related materials will be made available at
https://soft-ox.com/financial-calendar-reports/.

At 9:00 (CET) on the same day, the management will host a webcast presentation
in English. Please register for the presentation using the link below.

Registration: 

https://teams.microsoft.com/registration/GPWsOGT7vUCuf-It04UbWQ,oEPfirp3r0GbFmWN
BzTZNg,ebnx2uZTkE2EPvewJm782g,A7wyP47zO0yXrzMTR20aXA,QniapSBGZ0urCimjTSRqIw,ziH9
X8hk9U2QqA8bEDZFxg?mode=read&tenantId=38acf518-fb64-40bd-ae7f-e22dd3851b59

The presentation will be followed by a Q&A session. Questions can be submitted
in advance to ir@soft-ox.com. 

For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or
Kristine Rød, CFO at SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and
clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of
reducing the spread of infection and emergence of antimicrobial resistance. For
more information on SoftOx, visit www.soft-ox.com